An objective assessment of corporate value is only complete when a wide range of variables are considered from multiple angles. The Korea Financial Times uses the Altman Z-Score to evaluate the financial soundness and capital utilization of South Korea's top five pharmaceutical companies — Yuhan Corporation, GC Pharma, Chong Kun Dang, Daewoong Pharmaceutical, and Hanmi Pharmaceutical. This series aims to provide an in-depth examination of each company's current situation and strategic response, as well as the implications hidden in the flow of capital directed toward new future businesses.
<Editor's Note>
This infographic, originally published by Korea Financial Times, has been reconstructed using generative AI (Gemini).
Solid Finances, Underwhelming Returns: Yuhan Corporation's Capital Efficiency Challenge
이미지 확대보기
[Korea Financial Times, Yang Hyunwoo] Yuhan Corporation, the first domestic pharmaceutical company to surpass KRW 2 trillion in annual revenue, maintains the highest level of financial soundness in the industry. However, its efficiency in deploying capital falls short relative to its scale, earning the company a ranking of fourth out of the top five pharmaceutical companies.
댓글
0